Associated Banc-Corp’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.11M | Sell |
7,274
-12
| -0.2% | -$1.84K | 0.03% | 202 |
|
|
2025
Q4 | $1M | Sell |
7,286
-70
| -1% | -$9.17K | 0.03% | 207 |
|
|
2025
Q3 | $943K | Sell |
7,356
-745
| -9% | -$90.9K | 0.02% | 209 |
|
|
2025
Q2 | $980K | Sell |
8,101
-224
| -3% | -$25.2K | 0.03% | 206 |
|
|
2025
Q1 | $928K | Sell |
8,325
-165
| -2% | -$17.6K | 0.03% | 205 |
|
|
2024
Q4 | $826K | Sell |
8,490
-322
| -4% | -$34.3K | 0.02% | 212 |
|
|
2024
Q3 | $1.01M | Sell |
8,812
-40
| -0.5% | -$4.54K | 0.03% | 210 |
|
|
2024
Q2 | $942K | Buy |
8,852
+134
| +2% | +$13.5K | 0.03% | 205 |
|
|
2024
Q1 | $843K | Sell |
8,718
-103
| -1% | -$10.6K | 0.03% | 215 |
|
|
2023
Q4 | $891K | Sell |
8,821
-221
| -2% | -$21.3K | 0.03% | 207 |
|
|
2023
Q3 | $921K | Sell |
9,042
-240
| -3% | -$24.4K | 0.04% | 204 |
|
|
2023
Q2 | $937K | Sell |
9,282
-78
| -0.8% | -$7.8K | 0.04% | 204 |
|
|
2023
Q1 | $861K | Buy |
9,360
+185
| +2% | +$16.2K | 0.03% | 207 |
|
|
2022
Q4 | $832K | Buy |
9,175
+27
| +0.3% | +$2.27K | 0.03% | 202 |
|
|
2022
Q3 | $695K | Sell |
9,148
-215
| -2% | -$17.8K | 0.03% | 208 |
|
|
2022
Q2 | $792K | Sell |
9,363
-431
| -4% | -$37.8K | 0.03% | 201 |
|
|
2022
Q1 | $859K | Sell |
9,794
-424
| -4% | -$36.7K | 0.03% | 202 |
|
|
2021
Q4 | $894K | Sell |
10,218
-125
| -1% | -$10.4K | 0.03% | 200 |
|
|
2021
Q3 | $845K | Sell |
10,343
-356
| -3% | -$32K | 0.03% | 195 |
|
|
2021
Q2 | $977K | Sell |
10,699
-1,703
| -14% | -$152K | 0.04% | 191 |
|
|
2021
Q1 | $1.02M | Buy |
12,402
+875
| +8% | +$78.5K | 0.06% | 165 |
|
|
2020
Q4 | $1.09M | Sell |
11,527
-267
| -2% | -$23.3K | 0.04% | 209 |
|
|
2020
Q3 | $1.02M | Sell |
11,794
-696
| -6% | -$60.3K | 0.04% | 200 |
|
|
2020
Q2 | $1.09M | Sell |
12,490
-20
| -0.2% | -$1.73K | 0.05% | 197 |
|
|
2020
Q1 | $1.03M | Buy |
12,510
+1,070
| +9% | +$95.5K | 0.05% | 195 |
|
|
2019
Q4 | $1.08M | Sell |
11,440
-115
| -1% | -$10.3K | 0.05% | 182 |
|
|
2019
Q3 | $1M | Sell |
11,555
-654
| -5% | -$58.7K | 0.05% | 181 |
|
|
2019
Q2 | $1.11M | Sell |
12,209
-2,157
| -15% | -$183K | 0.06% | 177 |
|
|
2019
Q1 | $1.24M | Sell |
14,366
-212
| -1% | -$17K | 0.07% | 172 |
|
|
2018
Q4 | $1.12M | Buy |
14,578
+115
| +0.8% | +$8.95K | 0.07% | 172 |
|
|
2018
Q3 | $1.12M | Sell |
14,463
-11,129
| -43% | -$823K | 0.06% | 177 |
|
|
2018
Q2 | $1.73M | Sell |
25,592
-301
| -1% | -$20.8K | 0.1% | 153 |
|
|
2018
Q1 | $1.88M | Sell |
25,893
-1,940
| -7% | -$148K | 0.11% | 145 |
|
|
2017
Q4 | $2.09M | Sell |
27,833
-882
| -3% | -$66.5K | 0.11% | 145 |
|
|
2017
Q3 | $2.21M | Sell |
28,715
-1,865
| -6% | -$141K | 0.12% | 138 |
|
|
2017
Q2 | $2.29M | Sell |
30,580
-8,505
| -22% | -$603K | 0.13% | 132 |
|
|
2017
Q1 | $2.6M | Sell |
39,085
-874
| -2% | -$58.2K | 0.15% | 125 |
|
|
2016
Q4 | $2.61M | Sell |
39,959
-1,523
| -4% | -$98.8K | 0.16% | 119 |
|
|
2016
Q3 | $2.93M | Sell |
41,482
-549
| -1% | -$40K | 0.19% | 114 |
|
|
2016
Q2 | $3.11M | Buy |
42,031
+6
| +0% | +$415 | 0.2% | 110 |
|
|
2016
Q1 | $2.73M | Sell |
42,025
-1,819
| -4% | -$124K | 0.18% | 116 |
|
|
2015
Q4 | $3.38M | Sell |
43,844
-490
| -1% | -$38.9K | 0.22% | 102 |
|
|
2015
Q3 | $3.65M | Sell |
44,334
-502
| -1% | -$44.7K | 0.25% | 97 |
|
|
2015
Q2 | $3.95M | Sell |
44,836
-1,178
| -3% | -$108K | 0.25% | 101 |
|
|
2015
Q1 | $4.07M | Sell |
46,014
-1,432
| -3% | -$127K | 0.26% | 97 |
|
|
2014
Q4 | $3.94M | Sell |
47,446
-3,794
| -7% | -$314K | 0.25% | 98 |
|
|
2014
Q3 | $4.32M | Sell |
51,240
-342
| -0.7% | -$27.7K | 0.28% | 93 |
|
|
2014
Q2 | $4.18M | Sell |
51,582
-1,045
| -2% | -$82.2K | 0.27% | 97 |
|
|
2014
Q1 | $4.01M | Buy |
52,627
+417
| +0.8% | +$30.4K | 0.28% | 98 |
|
|
2013
Q4 | $3.76M | Buy |
52,210
+84
| +0.2% | +$5.84K | 0.27% | 92 |
|
|
2013
Q3 | $3.58M | Sell |
52,126
-2,921
| -5% | -$193K | 0.28% | 92 |
|
|
2013
Q2 | $3.49M | Buy |
+55,047
| New | +$3.58M | 0.29% | 92 |
|
Other funds holding NVS
Associated Banc-Corp's NVS Position: Q1 2026 in Review
Associated Banc-Corp reduced its Novartis (NVS) stake by 0.16% in Q1 2026, selling an estimated $1.84K and leaving 7,274 shares worth $1.11M. The position accounts for 0.03% of the portfolio, ranked #202.
Associated Banc-Corp first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.32M in Q3 2014. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Associated Banc-Corp held 7,274 shares of Novartis worth $1.11M as of Q1 2026.
- Associated Banc-Corp sold 12 Novartis shares in Q1 2026, an estimated $1.84K.
- Novartis made up 0.03% of Associated Banc-Corp's portfolio in Q1 2026, its #202 holding.
- Associated Banc-Corp first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
- Associated Banc-Corp's Novartis position peaked at $4.32M in Q3 2014.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Associated Banc-Corp's 13F filing for Q1 2026, filed 1 May 2026.